A modified blood adult stem-cell transplant regimen has effectively reversed sickle cell disease in 9 of 10 adults who had been severely affected by the disease, according to results of a National Institutes of Health study in the Dec. 10 issue of the New England Journal of Medicine. The trial was conducted at the NIH Clinical Center in Bethesda, Md., by NIH researchers at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the National Heart, Lung and Blood Institute (NHLBI), and the National Institute of Allergy and Infectious Diseases.
Twitter Comment
RT @fredcobio Blood-Stem Cell transplant cures sickle cell in 9 of 10 patients in NIH Clin trial: [link to post] | Incredible!!
– Posted using Chat Catcher
Twitter Comment
RT @fredcobio: Blood-Stem Cell transplant cures sickle cell in 9 of 10 patients in NIH Clin trial: [link to post]
– Posted using Chat Catcher